NCT Number: NCT00487227
Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function
It is often assumed that levels of caffeine found in 'decaffeinated' beverages are below any psychopharmacological threshold. However, recent findings indicate that caffeine doses as low as 9 mg may be psychoactive. The effects of caffeine have also been shown up to 6 hours post-administration. The study aimed to establish the lowest active dose of caffeine, and to ascertain the duration of any effects.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–35 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
The majority of recent caffeine studies have evaluated doses in the range of 75 - 150 mg or 1 - 2 mg/kg (approximately 130 - 260 ml fresh coffee). Such doses produce well characterised effects; including increased 'alertness', and improvements to measures of reaction time and sustained attention. A previous study has demonstrated improvements to performance following 9 mg caffeine, which represents the lowest known psychoactive dose of caffeine. A number of these effects, including elevated salivary caffeine levels, were still apparent at 6 hours post-caffeine consumption (9). Findings showing effects of 12.5 and 9 mg caffeine are important as these are approaching the levels found in decaffeinated beverages, which are assumed to have no behavioural or physiological effects. However, despite extensive research in this area, the lower threshold for psychoactive effects has not been established. A randomised, placebo-controlled, double-blind, balanced crossover study was undertaken. 20 young men and women (13 female, mean age 20.7 years, standard deviation 2.4) undertook computerised assessments of memory and attention and rated subjective mood. Autonomic activity and salivary caffeine were co-monitored. Assessment took place at baseline, 1, 3, 6, and 9 hours post-administration of placebo, 2.5, 5, and 10 mg caffeine (on separate days) administered in 150 ml fruit juice.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- native English speaker
Exclusion criteria
- pregnancy
- medication
- anaemia
- heart disorder
- diabetes
- respiratory disorder
- epilepsy
- asthma
- panic attacks
- habitual smoking
- food allergy
Treatment and study plan
Placebo
DrugPrimary outcomes
-
Change from baseline speed of attention
Time frame: 1 hour
-
Change from baseline speed of attention
Time frame: 3 hours
-
Change from baseline speed of attention
Time frame: 6 hours
-
Change from baseline speed of attention
Time frame: 9 hours
Secondary outcomes
-
Change from baseline accuracy of attention
Time frame: 1 hour
-
Change from baseline accuracy of attention
Time frame: 3 hours
-
Change from baseline accuracy of attention
Time frame: 6 hours
-
Change from baseline accuracy of attention
Time frame: 9 hours
-
Change from baseline speed of memory
Time frame: 1 hour
-
Change from baseline speed of memory
Time frame: 3 hours
-
Change from baseline accuracy of memory
Time frame: 6 hours
-
Change from baseline accuracy of memory
Time frame: 9 hours
-
Change from baseline subjective mood
Time frame: 1 hour
-
Change from baseline subjective mood
Time frame: 3 hours
-
Change from baseline subjective mood
Time frame: 6 hours
-
Change from baseline subjective mood
Time frame: 9 hours
-
Change from baseline blood pressure
Time frame: 1 hour
-
Change from baseline blood pressure
Time frame: 3 hours
-
Change from baseline blood pressure
Time frame: 6 hours
-
Change from baseline blood pressure
Time frame: 9 hours
-
Change from baseline heart rate
Time frame: 1 hour
-
Change from baseline heart rate
Time frame: 3 hours
-
Change from baseline heart rate
Time frame: 6 hours
-
Change from baseline heart rate
Time frame: 9 hours
-
Change from baseline salivary caffeine levels
Time frame: 1 hour
-
Change from baseline salivary caffeine levels
Time frame: 3 hours
-
Change from baseline salivary caffeine levels
Time frame: 6 hours
-
Change from baseline salivary caffeine levels
Time frame: 9 hours
Sponsors and collaborators
Lead sponsor
Northumbria University
Other
Registry information
Official study title
Levels of Caffeine Lower Than Those Found in Decaffeinated Beverages Exert Effects on Cognition, Mood, and Autonomic Activity
Important dates
- Study start
- 2005
- Study completion
- 2005
- First posted
- Jun 18, 2007
- Registry last updated
- Oct 8, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Interhemispheric Connectivity and Compensation
NCT05207878
Healthy, Peripheral Nerve Injury Upper Limb
St Louis, Missouri, United States
View Trial DetailsPhysical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype
NCT03876314
Alzheimer Disease, Behavior
Greensboro, North Carolina, United States
View Trial DetailsAI-driven Multiple Interactive Teaching Model on Nuclear Medicine Students' Theoretical Knowledge and Practical Skills
NCT07778186
Healthy, Nuclear Medicine Undergraduate Medical Education
Chengdu, Sichuan, China
View Trial DetailsTopical Tripelennamine 1% Cream Versus Diphenhydramine 1% Cream for the Relief of Histamine-Induced Itching: A Proof Concept Study in Healthy Adults.
NCT07778472
Healthy, Pathological Conditions, Signs and Symptoms
West Palm Beach, Florida, United States
View Trial Details